Skip to main content
Erschienen in: Neurological Sciences 2/2022

Open Access 03.11.2021 | Brief Communication

Falls risk is predictive of dysphagia in Parkinson’s disease

verfasst von: Christopher Kobylecki, Irena Shiderova, Mihaela Boca, Emilia Michou

Erschienen in: Neurological Sciences | Ausgabe 2/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Objective

Evaluate the relationship between falls, freezing of gait, and swallowing disturbance in Parkinson’s disease (PD).

Background

Dysphagia is a common symptom in PD, and is often thought of as an axial feature along with falls and gait disturbance. It is of interest to examine the relationship between these symptoms in PD, given the possibility of shared pathophysiology due to non-dopaminergic and extranigral dysfunction.

Methods

We recruited 29 consecutive non-demented patients with idiopathic PD and at least one clinically determined impairment in swallowing, falls, or freezing of gait. Swallow dysfunction was assessed using the Swallowing Disturbance Questionnaire (SDQ). The Falls Efficacy Scale and Freezing-of-gait questionnaire were recorded. Correlation analysis and multiple regression were used to determine the relationship between swallow and gait disturbance.

Results

Total SDQ score correlated strongly with the falls efficacy scale (Spearman’s rho = 0.594; P = 0.001), but not with the freezing-of-gait score. Linear regression controlling for other factors associated with dysphagia identified falls efficacy score as a significant predictor of swallow dysfunction.

Conclusions

The severity of dysphagia in PD is closely related to severity of falls, but not gait freezing. This may be helpful to more precisely determine the anatomical substrate of levodopa-resistant axial symptoms in PD and provide clues to further management.
Hinweise

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Dysphagia is a common feature of Parkinson’s disease (PD) and is implicated in potential adverse health outcomes such as aspiration pneumonia and hospitalization. Factors associated with dysphagia in PD include age, disease duration, and cognitive impairment [1]. However, while often considered as a feature of late-stage PD, swallowing impairments have been described earlier in the disease course, while the method of detecting dysphagia may influence the prevalence [2]. Dysphagia is often classed as a levodopa-resistant “axial” PD symptom, similar to gait problems including falls and freezing of gait (FOG) [3]. However, the relationship between dysphagia and axial gait disturbance in PD has not been assessed in detail.
We hypothesized that falls risk and freezing of gait would be associated with dysphagia in people with PD. Our aim was to recruit a sample of patients with gait disturbance and/or dysphagia to explore the relationship between these symptoms.

Methods

We performed a questionnaire-based study in 29 consecutive non-demented outpatients with PD who reported at least one symptom of swallow impairment, postural instability, or FOG. The study was approved by London Chelsea Research Ethics Committee (reference 17/LO/0384) and all participants gave written informed consent. We recorded demographic information and data on PD duration and medication doses; levodopa equivalent daily dose (LEDD) was calculated as previously described [4]. Dysphagia was assessed using the Swallow Disturbance Questionnaire [5], validated in PD to assess oral and pharyngeal components of swallow. Fear of falling was assessed with the Falls Efficacy Scale [6], while FOG was measured using the Freezing of Gait Questionnaire [7]. Statistical analysis was performed using SPSS 23.0 (IBM).

Results

The demographic characteristics of the study population and their questionnaire scores are detailed in Table 1. Postural instability was reported by 26 patients, whereas swallowing problems were reported by 14 and FOG by 19; 23 patients reported impairment in more than one domain (Fig. 1).
Table 1
Demographic characteristics and study outcomes. LEDD, levodopa equivalent daily dose; SDQ, Swallow Disturbance Questionnaire. Data are presented as mean (standard deviation) aside from those indicated with * which are median (interquartile range)
Variable
Result
Gender
Male 11
Female 18
Age (y)
70 (7.7)
Disease duration (y)
12.1 (5.7)
LEDD (mg)
975 (429)
SDQ oral*
3.0 (1.0–5.0)
SDQ pharyngeal*
4.5 (2.0–9.5)
SDQ total*
8.5 (2.0–14.5)
Falls efficacy scale total
46.8 (21.6)
Freezing of gait score
13.6 (5.2)
The FES total score correlated positively with SDQ total score (Spearman’s rho = 0.594; P = 0.001), as well as oral (rho = 0.619; P < 0.001) and pharyngeal subscales (rho = 0.563; P = 0.001). In contrast, neither SDQ total (rho = 0.176; P = 0.362) nor subscales showed a correlation with FOG Questionnaire score.
We performed multiple linear regression with total SDQ as the dependent variable using age, gender, disease duration, LEDD, and FES total score as predictive variables. In this model, FES total score was a significant predictor of SDQ score (standardized β = 0.533, P = 0.004), whereas other variables did not reach statistical significance.

Discussion

Our study shows that fear of falling, an indirect measure of falls risk, but not FOG is associated with dysphagia in a population of moderate-advanced PD without dementia. In addition, falls risk was predictive of dysphagia severity even when other factors previously linked with swallowing dysfunction were taken into account. These data suggest a link between these two axial PD symptoms beyond general disease progression. Walker and colleagues previously identified a correlation between dysphagia and falls identified by the Unified Parkinson’s Disease Rating scale part II, but did not use other validated assessment tools for these symptoms [8].
The causes of falls and gait disturbance in PD are multifactorial, but accumulating evidence points to dysfunction of the cholinergic pedunculopontine nucleus (PPN) as a key factor. Oropharyngeal swallowing is mainly controlled by the nucleus ambiguus, which is spared in PD but receives modulatory input from suprabulbar pattern generators including PPN [9]. We propose that degenerative changes in PPN could therefore provide a common substrate for parallel gait and swallow dysfunction in PD. However, further mechanistic work would be required to confirm this hypothesis.
The limitations of our work include a relatively small sample size but otherwise enriched for the presence of clinical features of interest. Despite having used a validated questionnaire for dysphagia in PD which has shown good sensitivity and specificity [5], we acknowledge that imaging techniques such as fiberoptic endoscopic evaluation of swallowing (FEES) can potentially verify swallowing problems. While gait was not assessed objectively, both FES and FOG questionnaire are recommended by current guidance in PD [10].
Our data suggest a specific relationship between falls and dysphagia in PD. The development of falls should alert clinicians to the possibility of other axial features like dysphagia. Further prospective work in a larger population and mechanistic studies of the role of brain areas such as PPN would help clarify this relationship.

Declarations

Ethical approval

The study received ethical approval as documented in the manuscript.
All participants gave written informed consent to participate.

Conflict of interest

The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Cereda E, Cilia R, Klersy C, Canesi M, Zecchinelli AL, Mariani CB et al (2014) Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord 20:1382–1387CrossRef Cereda E, Cilia R, Klersy C, Canesi M, Zecchinelli AL, Mariani CB et al (2014) Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord 20:1382–1387CrossRef
2.
Zurück zum Zitat Kalf JG, de Swart BJ, Bloem BR, Munneke M (2012) Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 18:311–315CrossRef Kalf JG, de Swart BJ, Bloem BR, Munneke M (2012) Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 18:311–315CrossRef
3.
Zurück zum Zitat Hely MA, Morris JG, Reid WG, Trafficante R (2005) Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–199CrossRef Hely MA, Morris JG, Reid WG, Trafficante R (2005) Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–199CrossRef
4.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRef Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRef
5.
Zurück zum Zitat Manor Y, Giladi N, Cohen A, Fliss DM, Cohen JT (2007) Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease. Mov Disord 22:1917–1921CrossRef Manor Y, Giladi N, Cohen A, Fliss DM, Cohen JT (2007) Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease. Mov Disord 22:1917–1921CrossRef
6.
Zurück zum Zitat Tinetti ME, Richman D, Powell L (1990) Falls efficacy as a measure of fear of falling. J Gerontol 45:P239–P243CrossRef Tinetti ME, Richman D, Powell L (1990) Falls efficacy as a measure of fear of falling. J Gerontol 45:P239–P243CrossRef
7.
Zurück zum Zitat Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E et al (2009) Validation of the freezing of gait questionnaire in patients with Parkinson’s disease. Mov Disord 24:655–661CrossRef Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E et al (2009) Validation of the freezing of gait questionnaire in patients with Parkinson’s disease. Mov Disord 24:655–661CrossRef
8.
Zurück zum Zitat Walker RW, Dunn JR, Gray WK (2011) Self-reported dysphagia and its correlates within a prevalent population of people with Parkinson’s disease. Dysphagia 26:92–96CrossRef Walker RW, Dunn JR, Gray WK (2011) Self-reported dysphagia and its correlates within a prevalent population of people with Parkinson’s disease. Dysphagia 26:92–96CrossRef
9.
Zurück zum Zitat Cersosimo MG, Benarroch EE (2012) Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 46:559–564CrossRef Cersosimo MG, Benarroch EE (2012) Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 46:559–564CrossRef
10.
Zurück zum Zitat Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B et al (2016) Measurement instruments to assess posture, gait, and balance in Parkinson’s disease: Critique and recommendations. Mov Disord 31:1342–1355CrossRef Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B et al (2016) Measurement instruments to assess posture, gait, and balance in Parkinson’s disease: Critique and recommendations. Mov Disord 31:1342–1355CrossRef
Metadaten
Titel
Falls risk is predictive of dysphagia in Parkinson’s disease
verfasst von
Christopher Kobylecki
Irena Shiderova
Mihaela Boca
Emilia Michou
Publikationsdatum
03.11.2021
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 2/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-021-05700-6

Weitere Artikel der Ausgabe 2/2022

Neurological Sciences 2/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.